<DOC>
	<DOCNO>NCT00307450</DOCNO>
	<brief_summary>The study design measure efficacy safety levetiracetam levodopa-induced dyskinesias late-stage Parkinson 's disease . The patient plan treat levetiracetam ( 2000 mg per day ) placebo 13 week . Efficacy measure modify AIMS .</brief_summary>
	<brief_title>Efficacy Safety Levetiracetam Versus Placebo Levodopa-induced Dyskinesias Advanced Parkinson 's Disease</brief_title>
	<detailed_description>The LeLeDys study design determine efficacy safety levetiracetam levodopa-induced dyskinesia advance Parkinson 's disease . The design multicenter , randomize , stratify , double-blinded , placebo-controlled phase IV study design . The hypothesis levetiracetam able reduce duration severity levodopa-induced dyskinesia Parkinson 's disease . The patient plan treat levetiracetam ( 2000 mg per day ) placebo 13 week . Efficacy measure modify AIMS . Main inclusion criterion : - Advanced Parkinson 's disease ( Hoehn &amp; Yahr II-IV ) - Age 30 80 year - Levodopa-induced dyskinesia least 25 % wake day moderate disability - Stable dosage antiparkinson medication and/or stable deep brain stimulation parameter least 4 week prior inclusion - Written inform consent Main exclusion criterion : - Atypical parkinsonian syndrome - Treatment antipsychotic - Epilepsia seizure history - Deep brain stimulation DBS STN - Pregnant lactate woman - Severe dementia Methods : - Primary outcome measure modify AIMS - Secondary outcome measure include UPDRS , safety , patient day record Study medication : - Levetiracetam ( upt 2000 mg / day ) - Matched Placebo</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Advanced Parkinson 's disease ( Hoehn &amp; Yahr IIIV ) Age 30 80 year Levodopainduced dyskinesias least 25 % wake day moderate disability Stable dosage antiparkinson medication and/or stable deep brain stimulation parameter least 4 week prior inclusion Written inform consent Atypical parkinsonian syndrome Treatment antipsychotic Epilepsia seizure history Deep brain stimulation DBS STN Pregnant lactate woman Severe dementia</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Dyskinesias</keyword>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Treatment</keyword>
</DOC>